muscle damage: creatine kinase and myoglobininflammation: IL-6 and IL-10
Conditions
Interventions
Group 1: 7 x 60mg cannabidiol-oil (1x /day)
Group 2: 7x 60mg cannabidol solution (1x /day)
Group 3: 7 x placebo
Sponsors
Deutsche Sporthochschule Köln, Institut für Kreislaufforschung und Sportmedizin, Abteilung 2 Molekulare und zelluläre Sportmedizin - Zentrum für präventive Doping Forschung
Eligibility
Sex/Gender
All
Age
18 Years to 40 Years
Inclusion criteria
Inclusion criteria: young healthy men and women
Exclusion criteria
Exclusion criteria: hormone substitution, including thyroid, hormone therapy, BMI >30, smokers, unbalanced diet (e.g. vegan), metabolic disorders, Treatment with insulin, sulfonylureas, glinides, GLP-1 analogs, those in need of treatment
Design outcomes
Primary
| Measure | Time frame |
|---|---|
| performance: 1RM back squat, 1RM bench press, 1.600m run muscle damage: CK und Myoglobin Inflammation: IL-6 und IL-10 Measurement time points: T0: before intervention, T1: immediately after intervention (one week after T0). | — |
Secondary
| Measure | Time frame |
|---|---|
| oxidative stress: - Ox-LDL - total antioxidative capacity - 8-Oxoguanin toxicity: - Gamma-glutamyltransferase - Alanine transaminase - Aspartate transaminase - creatinine Immune activity: - ratio: neutrophils - lymphocytes - ratio: thrombocytes - lymphocytes - systemic immune-inflammation index | — |
Countries
Germany
Contacts
Public ContactEduard Isenmann
DSHS Köln, Kreislaufforschung und Sportmedizin, Abt.2
Outcome results
None listed